Botox Competitor Jeuveau Launches A $49-A-Month Membership [Forbes]
Evolus, Inc. (EOLS)
Last evolus, inc. earnings: 2/25 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
us.evolis.com/investor-relations
Company Research
Source: Forbes
Evolus, the manufacturer behind neuromodulator Jeuveau, soft-launched its new membership, Club Evolus, in early November—a new option for budget-conscious consumers who are looking to keep up their neuromodulator treatment schedule. Club Evolus charges users $49 per month for a treatment consisting of 20 units of Jeuveau, available every 90 days. Depending on the provider, Jeuveau often costs around $13 per unit, meaning members can see about $113 in savings per treatment. The program has approximately 100 practices enrolled for 2024, with plans to expand in 2025. The introduction of Club Evolus arrives at an inflection point for the injectable aesthetics market. According to The American Society of Plastic Surgeons, there was a 9% increase in neuromodulator use between 2022 and 2023, the latest statistics available. That includes Jeuveau, Daxxify, Xeomin, and Botox, which temporarily freeze or relax muscles in areas like the forehead and eyes where wrinkles develop. However, the
Show less
Read more
Impact Snapshot
Event Time:
EOLS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EOLS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EOLS alerts
High impacting Evolus, Inc. news events
Weekly update
A roundup of the hottest topics
EOLS
News
- COSMETIC EXECUTIVE WOMEN (CEW) HONORS THE BEST IN BEAUTY [Yahoo! Finance]Yahoo! Finance
- Here's Why Evolus (EOLS) Could be Great Choice for a Bottom Fisher [Yahoo! Finance]Yahoo! Finance
- Down -29.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Evolus (EOLS) [Yahoo! Finance]Yahoo! Finance
- Earnings Update: Evolus, Inc. (NASDAQ:EOLS) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts [Yahoo! Finance]Yahoo! Finance
- Evolus, Inc. (NASDAQ: EOLS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $27.00 price target on the stock.MarketBeat
EOLS
Earnings
- 11/6/24 - Miss
EOLS
Sec Filings
- 11/14/24 - Form SCHEDULE
- 11/14/24 - Form SC
- 11/14/24 - Form SC
- EOLS's page on the SEC website